Major Surgical or Invasive Procedure: [**5-20**]: s/p Left femoral nail placement [**5-20**]: left femur and tibia compartment release and vac placement [**5-23**]: I&D and wound closure   History of Present Illness: The patient is a 17-y.o.
Pertinent Results: [**2112-5-19**] 07:45PM   FIBRINOGE-186 [**2112-5-19**] 07:45PM   PT-15.0* PTT-25.9 INR(PT)-1.3* [**2112-5-19**] 07:45PM   PLT COUNT-391 [**2112-5-19**] 07:45PM   WBC-27.0* RBC-4.40* HGB-13.4* HCT-39.1* MCV-89 MCH-30.5 MCHC-34.3 RDW-12.7 [**2112-5-19**] 07:45PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2112-5-19**] 07:45PM   LIPASE-42 [**2112-5-19**] 07:45PM   UREA N-15 CREAT-1.2 [**2112-5-19**] 08:03PM   freeCa-1.08* [**2112-5-19**] 08:03PM   HGB-13.9* calcHCT-42 O2 SAT-75 CARBOXYHB-2 MET HGB-0 [**2112-5-19**] 08:03PM   GLUCOSE-178* LACTATE-2.0 NA+-140 K+-3.7 CL--101 TCO2-25 [**2112-5-19**] 11:08PM   LACTATE-1.7  [**2112-5-19**]: CXR showed clear lungs.
[**2112-5-19**]: XR femur/tib/fib showed comminuted displaced fracture through the upper femoral diaphysis with mild varus angulation.
During this time, he also developed a pneumothorax, confirmed on CXR, and a chest tube was placed.
On [**2112-5-24**], the pneumothorax resolved and the chest tube was removed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day): Continue while on narcotics.
Oxycodone 20 mg Tablet Sustained Release 12 hr Sig: One (1) Tablet Sustained Release 12 hr PO Q12H (every 12 hours).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for breakthrough pain.
Milk of Magnesia 800 mg/5 mL Suspension Sig: Thirty (30) ML's PO twice a day.
Enoxaparin 40 mg/0.4 mL Syringe Sig: Forty (40) MG Subcutaneous DAILY (Daily) for 4 weeks.
It is important that you walk several times during the day to help with circulation and to minimize risks of developing blood clots.
You have been prescribed Lovenox injections by Orthopedics; this is a blood thinner to help prevent blood clots.
